1. Home
  2. KRUS vs TECX Comparison

KRUS vs TECX Comparison

Compare KRUS & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kura Sushi USA Inc.

KRUS

Kura Sushi USA Inc.

HOLD

Current Price

$46.46

Market Cap

650.6M

ML Signal

HOLD

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$29.58

Market Cap

549.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRUS
TECX
Founded
2008
2019
Country
United States
United States
Employees
N/A
60
Industry
Restaurants
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
650.6M
549.5M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
KRUS
TECX
Price
$46.46
$29.58
Analyst Decision
Buy
Strong Buy
Analyst Count
9
5
Target Price
$81.11
$75.20
AVG Volume (30 Days)
374.4K
170.8K
Earning Date
04-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
79.75
N/A
EPS
N/A
N/A
Revenue
$282,763,000.00
N/A
Revenue This Year
$20.50
N/A
Revenue Next Year
$20.68
N/A
P/E Ratio
N/A
N/A
Revenue Growth
18.88
N/A
52 Week Low
$42.62
$14.39
52 Week High
$95.98
$35.99

Technical Indicators

Market Signals
Indicator
KRUS
TECX
Relative Strength Index (RSI) 40.40 53.66
Support Level $42.81 $27.31
Resistance Level $58.75 $31.39
Average True Range (ATR) 2.98 1.97
MACD -0.49 -0.01
Stochastic Oscillator 24.98 52.05

Price Performance

Historical Comparison
KRUS
TECX

About KRUS Kura Sushi USA Inc.

Kura Sushi USA Inc is a technology-enabled Japanese restaurant concept that provides guests with a distinctive dining experience by serving authentic Japanese cuisine through an engaging revolving sushi service model. The company operates a chain of sushi restaurants across the United States serving freshly prepared Japanese cuisine using high-quality ingredients that are free from artificial seasonings, sweeteners, colorings, and preservatives. The company operates a network of dine-in locations across the U.S. states and Washington, DC.

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Share on Social Networks: